Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bertoli

Showing results (21-30 of 168) with videos related to

Pageof 17
Sort By:
Thrombosis Research|June 11, 1998
Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysisG Luzzatto, M Bertoli, G Cella, et al.
Zygote (Cambridge, England)|November 1, 1995
Intracytoplasmic sperm injection in dysmorphic human oocytesM Alikani, G Palermo, A Adler, et al.
Annals of the Rheumatic Diseases|August 28, 2007
Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupusA M Bertoli, L M Vilá, J D Reveille, et al.
The Journal of Rheumatology|November 13, 2008
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damageAna M Bertoli, Luis M Vilá, John D Reveille, et al.
The Journal of Clinical Investigation|July 1, 1992
Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2A Ammar, Y Sahraoui, A Tsapis, et al.
Cellular Immunology|December 1, 1993
IL2-R alpha chain inhibitory factor (p29) produced by HIV-infected macrophages: cell target and mode of actionA Ammar, A M Bertoli, S Chouaib, et al.
The Journal of Clinical Investigation|June 1, 1991
Biological and biochemical characterization of a factor produced spontaneously by adherent cells of human immunodeficiency virus-infected patients inhibiting interleukin-2 receptor alpha chain (Tac) expression on normal T cellsA Ammar, C Cibert, A M Bertoli, et al.
Contemporary Clinical Trials|June 22, 2007
Lack of correlation between satisfaction and knowledge in clinical trials participants: a pilot studyAna M Bertoli, Ingrid Strusberg, Gonzalo A Fierro, et al.
Medicina|April 16, 2005
[Use of infliximab in patients of a rheumatologic center]Ingrid Strusberg, Ana M Bertoli, Ruth C de Pizzolato, et al.
La Radiologia Medica|March 1, 1985
[Echography in the diagnosis of spontaneous hematoma of the rectus muscle]F Corbetti, M Donadi, G Tomasella, et al.
Pageof 17

Showing results (21-30 of 168) with videos related to

Sort By:
Pageof 17
Thrombosis Research|June 11, 1998
Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysisG Luzzatto, M Bertoli, G Cella, et al.
Zygote (Cambridge, England)|November 1, 1995
Intracytoplasmic sperm injection in dysmorphic human oocytesM Alikani, G Palermo, A Adler, et al.
Annals of the Rheumatic Diseases|August 28, 2007
Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupusA M Bertoli, L M Vilá, J D Reveille, et al.
The Journal of Rheumatology|November 13, 2008
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damageAna M Bertoli, Luis M Vilá, John D Reveille, et al.
The Journal of Clinical Investigation|July 1, 1992
Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2A Ammar, Y Sahraoui, A Tsapis, et al.
Cellular Immunology|December 1, 1993
IL2-R alpha chain inhibitory factor (p29) produced by HIV-infected macrophages: cell target and mode of actionA Ammar, A M Bertoli, S Chouaib, et al.
The Journal of Clinical Investigation|June 1, 1991
Biological and biochemical characterization of a factor produced spontaneously by adherent cells of human immunodeficiency virus-infected patients inhibiting interleukin-2 receptor alpha chain (Tac) expression on normal T cellsA Ammar, C Cibert, A M Bertoli, et al.
Contemporary Clinical Trials|June 22, 2007
Lack of correlation between satisfaction and knowledge in clinical trials participants: a pilot studyAna M Bertoli, Ingrid Strusberg, Gonzalo A Fierro, et al.
Medicina|April 16, 2005
[Use of infliximab in patients of a rheumatologic center]Ingrid Strusberg, Ana M Bertoli, Ruth C de Pizzolato, et al.
La Radiologia Medica|March 1, 1985
[Echography in the diagnosis of spontaneous hematoma of the rectus muscle]F Corbetti, M Donadi, G Tomasella, et al.
Pageof 17